Natalie Dayan
McGill University Health Centre
Internal medicineObstetricsSurgeryOdds ratioRetrospective cohort studyPediatricsCohort studyHazard ratioObservational studyPreeclampsiaAcute coronary syndromeDiseasePregnancyGestational diabetesMEDLINEPopulationGynecologyMaternal morbidityPostpartum periodNormotensive pregnancyBioinformaticsMedicineCohortRelative riskMeta-analysis
Publications 53
#1Nathalie AugerH-Index: 27
#2U. Vivian UkahH-Index: 1
Last. Natalie DayanH-Index: 13
view all 0 authors...
#2Isabelle Malhamé (MUHC: McGill University Health Centre)H-Index: 7
Last. Nadine Sauvé (Université de Sherbrooke)H-Index: 5
view all 9 authors...
BACKGROUND Pelvic vein thrombosis (PVT) is a rare complication of pregnancy that can lead to life-threatening complications, such as pulmonary embolism (PE). OBJECTIVE To describe characteristics of PVT and its treatment in pregnancy in the province of Quebec, Canada. PATIENTS/METHODS We developed a province-wide case series of PVT in pregnancy including four tertiary care centres and the Registry of Rare Diseases of the Groupe d'Etude en Medecine Obstetricale du Quebec. Using diagnostic codes, ...
#1Glen J. Pearson (U of A: University of Alberta)H-Index: 20
#2George Thanassoulis (McGill University)H-Index: 25
Last. Wendy Wray (MUHC: McGill University Health Centre)
view all 26 authors...
The 2021 guidelines primary panel selected clinically relevant questions and produced updated recommendations, on the basis of important new findings emerging since the 2016 guidelines. In subjects with clinical atherosclerosis, abdominal aortic aneurysm, most subjects with diabetes or chronic kidney disease, and those with low-density lipoprotein cholesterol (LDL-C) ≥5 mmol/L, statin therapy continues to be recommended. We have introduced the concept of lipid/lipoprotein treatment thresholds fo...
#1U. Vivian Ukah (MUHC: McGill University Health Centre)H-Index: 1
#2Natalie DayanH-Index: 13
Last. Nathalie AugerH-Index: 27
view all 5 authors...
OBJECTIVE To examine long-term risks of mortality after a pregnancy complicated by severe maternal morbidity. METHODS We analyzed a longitudinal cohort of 1,229,306 women who delivered in the province of Quebec, Canada from 1989 through 2016. Severe maternal morbidity included conditions such as cerebrovascular accidents, acute renal failure, severe preeclampsia, and other life-threatening complications. The outcome was in-hospital mortality after the last pregnancy, categorized as postpartum (4...
1 CitationsSource
#1Kara NerenbergH-Index: 20
#2Anne-Marie CôtéH-Index: 20
Last. Diana SherifaliH-Index: 23
view all 12 authors...
#1Natalie DayanH-Index: 13
Last. Joel G. RayH-Index: 4
view all 9 authors...
Objective: To improve the prediction of maternal end-organ injury or death using routinely-collected variables from the pre-pregnancy and the early pregnancy period. Design: Population-based cohort study using linked administrative health data. Setting: Ontario, Canada, April 1, 2006 to March 31, 2014. Sample: Women aged 18-60 years with a livebirth or stillbirth, of which one birth was randomly selected per woman. Methods and main outcome measures: We constructed a CPM for the primary composite...
#1Miriam Harris (BU: Boston University)H-Index: 3
#2Emily G. McDonald (McGill University)H-Index: 16
Last. Natalie Dayan (MUHC: McGill University Health Centre)H-Index: 13
view all 10 authors...
Abstract Objective We aimed to describe opioid prescribing practices after obstetric delivery and to evaluate how these practices compare with national opioid prescribing guidelines. Methods A closed survey was developed, evaluated for validity and reliability, and distributed by email to obstetrician members of the Society of Obstetricians and Gynaecologists of Canada (SOGC) in December 2018. Descriptive statistics were used to summarize respondent demographics, pharmaceutical pain management s...
#1Isabelle Malhamé (MUHC: McGill University Health Centre)H-Index: 7
#2Vicky Tagalakis (JGH: Jewish General Hospital)H-Index: 23
Last. Natalie Dayan (MUHC: McGill University Health Centre)H-Index: 13
view all 3 authors...
Abstract Pulmonary embolism (PE) complicates 5.4 per 10 000 pregnancies and remains a significant cause of maternal mortality. Prompt diagnosis and treatment of PE is key to ensuring optimal outcomes, but not without the risks of over-testing, owing to a lack of validated risk-prediction algorithms in the obstetric setting. Given the paucity of evidence informing PE diagnosis in pregnancy, marked heterogeneity exists among different societies in their recommendations. Here we provide an overview...